MPO and brain infarction: In addition, MLIF decreased cerebral infarction areas and the level of malondialdehyde (MDA), myeloperoxidase (MPO), tumor necrosis factor-alpha (TNF-α), and IL-1β and increased the level of superoxide dismutase (SOD) (Yao et al., 2011).